A Rapid, Field‐Deployable Diagnostic Platform for Getah Virus Based on RT ‐ RAA and CRISPR EsCas13d
Microbial Biotechnology · 2026
DOI: 10.1111/1751-7915.70429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Biotechnology, 2026. Verfasst von Liu Baoling und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Nucleic Acid Amplification Techniques, CRISPR-Cas Systems. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China during the 14th Five-Year Plan: Research and Development of Key Technologies for the Prevention and Cont…, Research and Application of Integrated Prevention, Control and Purification Technologies for Major Swine Epidemic Diseases, Sichuan Province Major Science and Technology Project for Sichuan Pigs during the 14th Five-Year Plan Period.
Abstract (Originalsprache)
The emerging zoonotic Getah virus (GETV) poses an increasing threat to both animal and human health, underscoring the need for rapid, sensitive and field‐deployable diagnostic tools. In this study, we developed and optimized a rapid, one‐step, visual detection (ROSVD) platform for GETV by integrating reverse transcription recombinase‐aided amplification (RT‐RAA) with CRISPR‐EsCas13d‐mediated collateral RNA cleavage. Notably, the ROSVD assay uses a simplified sample‐preparation strategy based on rapid nucleic acid release, eliminating the need for conventional nucleic acid extraction and purification. The entire workflow, including amplification and detection, is completed within 30 min at 37°C or ambient temperature (25°C) without specialized instrumentation. Detection results can be visualized directly under ultraviolet light or with a lateral flow assay. At 37°C, the ROSVD assay achieved sensitivity comparable to RT‐qPCR, and evaluation of clinical specimens showed 100% concordance with RT‐qPCR results. Collectively, these findings demonstrate that ROSVD is a rapid, sensitive, cost‐effective and instrument‐independent diagnostic platform, providing a practical solution for on‐site surveillance of GETV and a versatile framework for the detection of other emerging RNA pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, China.
ORCID-Profile: Liu Baoling, Shao Lina, Xu Tong, Jia Qinrui, Zhu Ling, Xu Zhiwen
Förderung
- National Key Research and Development Program of China during the 14th Five-Year Plan: Research and Development of Key Technologies for the Prevention and Cont…
- Research and Application of Integrated Prevention, Control and Purification Technologies for Major Swine Epidemic Diseases
- Sichuan Province Major Science and Technology Project for Sichuan Pigs during the 14th Five-Year Plan Period
- Sichuan Pig Innovation Team of the National Modern Agricultural Industry Technology System
Zitieren
APA
Baoling, L., Lina, S., Tong, X., Qinrui, J., Ling, Z., & Zhiwen, X. (2026). A Rapid, Field‐Deployable Diagnostic Platform for Getah Virus Based on RT ‐ RAA and CRISPR EsCas13d. Microbial Biotechnology. https://doi.org/10.1111/1751-7915.70429
Vancouver
Baoling L, Lina S, Tong X, Qinrui J, Ling Z, Zhiwen X. A Rapid, Field‐Deployable Diagnostic Platform for Getah Virus Based on RT ‐ RAA and CRISPR EsCas13d. Microbial Biotechnology. 2026. doi:10.1111/1751-7915.70429
BibTeX
@article{Baoling2026,
author = {Baoling, Liu and Lina, Shao and Tong, Xu and Qinrui, Jia and Ling, Zhu and Zhiwen, Xu},
title = {A Rapid, Field‐Deployable Diagnostic Platform for Getah Virus Based on RT ‐ RAA and CRISPR EsCas13d},
journal = {Microbial Biotechnology},
year = {2026},
doi = {10.1111/1751-7915.70429}
}
EUVIMED